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Genome-wide association studies (GWAS) have found hundreds of novel loci associated
with full blood count (FBC) phenotypes. However, most of these studies were
performed in a single phenotype framework without putting into consideration the clinical
relatedness among traits. In this work, in addition to the standard univariate GWAS, we
also use two different multivariate methods to perform the first multiple traits GWAS of
FBC traits in ∼7000 individuals from the Ugandan General Population Cohort (GPC).
We started by performing the standard univariate GWAS approach. We then performed
our first multivariate method, in this approach, we tested for marker associations with
15 FBC traits simultaneously in a multivariate mixed model implemented in GEMMA
while accounting for the relatedness of individuals and pedigree structures, as well as
population substructure. In this analysis, we provide a framework for the combination
of multiple phenotypes in multivariate GWAS analysis and show evidence of multi-
collinearity whenever the correlation between traits exceeds the correlation coefficient
threshold of r2 >=0.75. This approach identifies two known and one novel loci. In
the second multivariate method, we applied principal component analysis (PCA) to
the same 15 correlated FBC traits. We then tested for marker associations with each
PC in univariate linear mixed models implemented in GEMMA. We show that the
FBC composite phenotype as assessed by each PC expresses information that is not
completely encapsulated by the individual FBC traits, as this approach identifies three
known and five novel loci that were not identified using both the standard univariate and
multivariate GWAS methods. Across both multivariate methods, we identified six novel
loci. As a proof of concept, both multivariate methods also identified known loci, HBB
and ITFG3. The two multivariate methods show that multivariate genotype-phenotype
methods increase power and identify novel genotype-phenotype associations not found
with the standard univariate GWAS in the same dataset.
Keywords: multivariate GWAS, PCA, full blood counts, multiple phenotype, genome-wide association study
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INTRODUCTION
Genome-wide association studies (GWAS) have discovered
loci associated with a extensive range of human traits and
diseases. Mostly, the standard univariate GWAS approach
has been performed in a single trait framework without
putting into consideration clinical relatedness and correlations
among phenotypes. However, as many human traits are highly
correlated, given the usual stringent statistical genome-wide
significance threshold, such analyses may have a number of
limitations including difficulties in identifying genetic risk
factors implicating pleiotropic effects (Park et al., 2011).
Current large-scale standard univariate and multivariate GWAS
analyses have principally concentrated on the populations of
European lineage (Need and Goldstein, 2009; Zhang et al.,
2009; Galesloot et al., 2014; Porter and O’Reilly, 2017) with
only a few small-scale GWAS in African populations across a
narrow range of cardiometabolic diseases and traits (Gurdasani
et al., 2015; Peprah et al., 2015). In order to generalize
the discoveries from genetic studies of complex diseases and
provide opportunities for new understandings into disease
etiology and potential therapeutic strategies, it will be vital
to investigate the genetic susceptibility in a global setting,
including populations of African ancestry (McCarthy et al., 2008;
Adoga et al., 2014).
Multivariate linear mixed models have been extensively
used in a range of genetics studies (Yu et al., 2006; Kang
et al., 2008, 2010; Zhang et al., 2010; Lippert et al., 2011;
Loh et al., 2015; Hackinger and Zeggini, 2017). Recently this
approach has attracted substantial topical interest in GWAS.
Genome-wide Efficient Mixed Model Association (GEMMA)
(Zhou and Stephens, 2014) models a multivariate linear
mixed model to test SNPs associations with multiple traits
simultaneously while adjusting for population stratification.
In previous studies, multivariate analyses have mainly been
performed on GWAS of lipids traits (Park et al., 2011)
and anthropometry traits (Ried et al., 2016) mostly in the
European and Asian populations. As cellular components of the
full blood count (FBC) arise from a common pluripotent
stem cell (Seet et al., 2017) and are highly correlated.
Thus, FBC traits provide an opportunity to: (1) explore
how multivariate GWAS performs in comparison with
standard univariate analyses in a family-based dataset, (2)
investigate the effect of highly correlated traits in multivariate
analyses, (3) explore different multivariate approaches in
GWAS, and (4) understand when a multivariate analysis
would be most helpful in a GWA study. In the present
study, we performed the first multivariate GWAS of FBC
traits by analyzing quality controlled 2,230,258 autosomal
SNPs in nearly 7000 individuals who are structured in
clustered groups in rural Uganda, genotyped on the
Illumina Human Omni 2.5 M octo array. We applied a
two way complementary multivariate GWAS strategies
in nearly 5000 genotyped samples and validation of the
associated genetic variants in ∼2000 individuals with whole
genome sequencing (WGS) sampled from Ugandan General
Population Cohort (GPC).
MATERIALS AND METHODS
Study Population
General Population Cohort is a population-based open cohort
of roughly 22,000 inhabitants around 25 neighboring villages
of Kyamulibwa, which is a subcounty of Kalungu district in
countryside south-west of Uganda (Figure 1). The cohort study
was founded in the late 80s by the Medical Research Council
(MRC) United Kingdom in partnership with the Uganda Virus
Research Institute (UVRI) to primarily investigate the trends
in incidence and prevalence of HIV infection in Uganda.
Samples were collected from research participants during a
survey from the research study area. The study area is clustered
into villages defined by governmental borders ranging in size
from 300 to 1500 dwellers and includes numerous families
resident within households (Asiki et al., 2013). The GPC Round
22 study took place in 2011 through collaboration between
the University of Cambridge, Wellcome Sanger Institute (WSI),
and MRC/UVRI. The study was contained within one annual
survey round of the longitudinal cohort. The focus of the
GPC Round 22 study was to investigate the genetics and
epidemiology of communicable and non-communicable diseases
to provide etiological insights into the genetic variation in
cardiometabolic and infectious risk factors in children and adults
using both population genetic and epidemiological approaches.
The first set of samples tagged UGWAS was constituted of
∼5000 Uganda subjects genotyped on the HumanOmni2.5-8
Illumina genotyping chip array. Following a stringent quality
control (see section “Quality Control”), 4778 individuals were
carried further for analysis. The later set of samples tagged
UG2G were ∼2000 individuals who underwent whole genome
sequencing, of these 1,629 individuals passed quality checks and
were non-overlapping with the genotype data. Both UGWAS and
UG2G included several pedigrees, and individuals with cryptic
relatedness, as well as individuals clustered by household and
village. Due to extensive migration into and around the region,
nine ethno linguistic groups in south-western Uganda were
included in the sample.
Study Design
The data collection of GPC Round 22 study contained five
main stages which took place in 2011 over the course of
the year: mobilization (recruitment and consenting), mapping,
census, survey, and feedback of results and clinical follow-
up. The census consisted of a family questionnaire and
questionnaire for the individual recruited from within the
family. The family questionnaire was completed by the head
of family or another responsible adult or emancipated minor
member of the household. The household census questionnaire
focused on sociodemographic information about the household,
such as the quality of the house, property ownership, and
employment of workers. The individual survey questionnaire
captured information on members of a household including
position within household, marital status, resident status,
childbirth, and fertility, tribe, and religion. Information on
lifestyle and health was obtained using a standard questionnaire.
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FIGURE 1 | Study area in Kyamulibwa sub-region.
This included biophysical measurements and blood samples
(Asiki et al., 2013). To assess the spectrum of genetic variants
associated with cardiometabolic traits in this population, we
previously performed a standard univariate GWAS in a range
of individual cardiometabolic traits. In the current study,
we applied two different multivariate GWAS methods in
analyzing multiple related FBC phenotypes simultaneously
following a standard univariate GWAS analysis of the individual
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trait. We assessed the autosomal common SNPs in the
imputed genotyped data (UGWAS) and sequenced UG2G
in a pooled analyses comprising of 6407 all individuals,
rather than a meta-analysis which would consider these
as independent datasets and potentially result in inflation
of type I error.
Quality Control
Briefly, we applied stringent quality control filtering to carry out
a succession of sequential quality control steps on∼5000 Uganda
samples genotyped on an Illumina array. Specifically, a total of
2,314,174 autosomal variants were genotyped on the illumine
HumanOmni2.5-8 array. We excluded 39,368 autosomal variants
who did not pass the stringent quality control cutoff for the
variants (Heckerman et al., 2016). We also excluded a total
of 91 individuals during sample QC as they fail to meet the
quality control cutoffs for the samples call rate (>97%) or for
the heterozygosity in the range of mean ± 3SD, or because
they fail the gender check criteria using the X-chromosome as
a match. Three samples were also excluded because of they
are too related to one another using identical by descent (IBD
>0.90) (Heckerman et al., 2016). Downstream analyses were
performed on the remaining 2,230,258 autosomal markers and
4,778 samples which passed quality checks. The workflow for data
processing of UG2G has been previously described in more detail.
Genotype Imputation
Imputation was carried out on pre-phased data with IMPUTE2
(Howie et al., 2009) using a merged reference panel of the whole
genome sequence data from the African Genome Variation
Project (Gurdasani et al., 2015), the UG2G described earlier
and the 1000 Genomes phase 3 project (1000 Genomes Project
Consortium, 2015) following standard recommendations.
Imputation was carried out in chunks of two MB and then
concatenated. In order to allow the most accurate different
downstream analyses, imputed SNPs were further filtered
at info statistics of 0.3 and a minor allele frequency (MAF)
threshold of 0.5%. All duplicated sites and variants were also
removed from the data. Analyses were carried out on the final
set of 18,868,552 QC imputed data. This approach removed all
monomorphic variants from the data which is based on Genome
Research Consortium human build 37 also called the Human
genome build 19.
Phenotype Definition and Transformation
Fifteen FBC traits were measured using the Beckman Coulter
ACT5 Diff CP hematology analyzer (Table 1). We carried out
the inverse normal transformation of each trait residual. First, we
obtained residuals after the regression of each trait on age, age2,
and sex. We then inverse normally transformed the residuals
for GWAS analysis.
Evaluation for Systematic Difference
Between Genotype and Sequence Data
Following merger of imputed genotype and sequence data,
we first examined if systematic differences existed between
TABLE 1 | A description of phenotypic traits analyzed in the total 6407 individuals
in the pooled dataset.
Traits Unit Number of
analyzed
samples
Mean Standard
Deviation
White blood cell (WBC) ×109/l 1625 5.17 1.52
Red blood cell (RBC) ×109/l 1625 4.72 0.61
Mean corpuscular volume (MCV) fl 1625 85.9 7.77
Mean cell hemoglobin (MCH) pg/cell 1625 28.9 2.93
Mean cell hemoglobin
concentration (MCHC)
g/L 1625 33.63 1.18
Red blood cell distribution width
(RDW)
% 1625 13.11 1.37
Packed cell volume (PCV) l/l 1625 40.31 4.61
Hemoglobin g/L 1625 13.56 1.6
Mean platelet volume (MPV) fL 1624 8.65 0.81
Platelet count (PLT) x109/l 1625 219 79.1
Lymphocyte count % 1565 48.64 9.9
Monocyte count % 1565 5.65 1.93
Basophil count % 1565 0.91 1.03
Neutrophil count % 1415 38.02 10.5
Eosinophil count % 1555 6.73 6.50
imputed genotype data and sequence data (Figure 2). We
carried out principal component analysis (PCA) on these data to
examine whether there was separation by data mode (imputed
genotype data and sequenced data). We noted clear separation
of data points of genotype imputed and sequence data on
PCA. In order to minimize systematic effects, we examined
the 343 samples that had been genotyped and sequenced in
duplicate. Using these samples, we evaluated different thresholds
of concordance between sequence and imputed genotype data for
identical samples, filtering out SNPs that showed a concordance
<0.80 and <0.90, in the 343 samples. We found that a
minimum concordance threshold of 0.90 was required to
abolish systematic effects observed between genotype array and
sequence data on PCA.
Following exclusion of 904,283 variants (2.3% of all variants)
that showed <90% concordance in genotypes between the
sequence and imputed genotype data (for 343 samples that
had been genotyped and sequence), PCAs did not show any
systematic differences between imputed genotype and sequence
data. We inspected the first ten PCs to ensure that systematic
differences did not represent an important axis of variation in the
genetic data. Following filtering, a total of 39,312,112 autosomal
markers in the joint set of 6,407 samples were taken forward
for analyses. For GWAS association analyses, we only included
a subset of variants (n = 20,594,556) that met an MAF threshold
of at least 0.5%.
Statistical Methods for Association
Analysis
We used the exact linear mixed model approach implemented
in GEMMA version 24 for analysis of pooled data from 6,407
individuals in GPC. We evaluated different approaches for
generation of the kinship matrix to control type I error in
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FIGURE 2 | Separation on PCA between genotype and Sequence data using different filters. Panel (A) shows separation of sequenced and imputed genotyped
samples in pooled PCA analysis of 6,407 individuals from UGR along PC 1. On filtering of variants that showed <80% concordance between sequenced and
genotype data in a set of 343 individuals who were genotyped and sequenced, this separation was reduced, and became a secondary axis of variation (along PC 2)
(B). Panel (C) shows that separation along PCs 1 and 2 is removed on filtering variants with concordance <90% between sequenced and genotyped data.
analysis. It has been shown that inclusion of causal SNPs in
the kinship matrix can lead to overly conservative results for
these SNPs, and reduction in power for GWAS discovery. In
order to maximize discovery, we used the leave one chromosome
out (LOCO) approach for analysis (Listgarten et al., 2012; Yang
et al., 2014). In this approach each chromosome is excluded
from generation of the kinship matrix in turn, for association
analysis for markers along that chromosome. This ensures that
causal SNPs at a locus on a given chromosome are not used for
generation of the kinship matrix used in analysis of that specific
chromosome. Therefore, we generated 22 kinship matrices for
analysis, each excluding the chromosome being analyzed using
the given matrix.
For computational efficiency, and to avoid correlation effects
due to LD, we LD pruned the data prior to calculation of the
GRM matrix for each LOCO analysis. We carried out sensitivity
analyses using different r2 thresholds for pruning, to examine
whether type I error was appropriately controlled on examining
genomic inflation factors from QQ plots. We finally used all
markers with an MAF >1%, pruned to an r2 threshold of 0.5,
using PLINK (Purcell et al., 2007) with the flags –maf 0.05 and –
indep-pairwise 100 10 0.5, where 0.01 is the minimum MAF
threshold of 1% and 0.5 is the r2 threshold within each 100
marker window sliding by a step size of 10 markers during each
iteration. All genomic inflation factors for traits were noted to be
below 1.05 using this approach.
We also included a covariate to indicate whether data
originated from imputed genotyped individuals or sequenced
individuals to allow for any systematic differences between
data (although earlier PCA suggested no systematic effects
in filtered data). A MAF threshold of 0.5% was applied
in GEMMA analysis. The 20674434 variants that passed all
quality control (QC) criteria were tested for associations using
the standard univariate (UV-GWAS), multivariate approach
(MV-GWAS) and principal component approach (PC-GWAS).
These methods were described in the Sub-sections “Univariate
GWAS Method (UV-GWAS), Multivariate GWAS Method
(MV-GWAS), and Principal Component GWAS Method (PC-
GWAS).” For each analysis, the P-values were calculated using
the likelihood ratio test.
Univariate GWAS Method (UV-GWAS)
Here, we carried out a genome wide association study of 15
FBC traits (Table 1) using the standard univariate approach.
We examined the association between a single trait at a time
with SNPs taking into consideration issues with relatedness and
population stratification. We show the distribution of association
P-values for the 15 traits in QQ plots (Supplementary Figure 1).
The genomic inflation factor for each analysis ranges from
between 0.99 and 1.01 suggesting there is no genome-wide
inflation due to population stratification. We show a summary
of all genome-wide significant variants in Table 2.
Multivariate GWAS Method (MV-GWAS)
For the multivariate GWAS analysis, we started by testing
for marker associations in a multivariate linear mixed model
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TABLE 2 | Description of genome-wide significant loci using the standard univariate GWAS approach.
Peak SNP AF Association count Chr BP (GRCh37) Gene Trait Pooled analysis P-value
rs334 0.923 46 11 5248232 HBB∗ RDW 5.56E-17
rs13331259 0.897 230 16 299923 ITFG3∗ RBC, MCV, MCH, MCHC 1.23E-30
rs1347767 0.152 277 2 136485657 R3HDM1∗ Neutrophil count 7.81E-12
19:16213697 0.862 4 19 16213697 TPM4∗ MPV 4.62E-10
rs12534473 0.502 1 7 106374548 CTB-30L5.1 MPV 2.00E-08
rs7725036 0.742 1 5 97438982 AC008834.1 RBC 4.71E-08
rs142586351 0.9 1 19 21800425 – Eosinophil count 2.78E-08
rs2769976 0.909 1 20 48514919 – Eosinophil count 5.90E-09
∗Known association; AF, allele frequency.
FIGURE 3 | (A) Manhattan plot of genome-wide associations for FBC (15 full blood count traits). Each point denotes a variant, with the X-axis representing the
genomic position and Y-axis representing the association level -log 10 (P-value) for the association of all variants with MAF >=0.005. The dotted line shows the
genome-wide significant P-value of 5 × 10–8. (B) Visually inflated QQ plot of genome-wide associations for FBC (15 full blood count traits) with an inflation
factor of 0.97.
in GEMMA with all the 15 FBC traits simultaneously while
we controlled for population stratification without giving
consideration to the level of correlations among these traits. We
plotted the resulting P-values from this association analysis and
showed the Manhattan and QQ plots in Figures 3A,B. We noted
an unconventional Manhattan plot (Figure 3A) showed genome-
wide significant variants at almost every chromosome and the
QQ plot showed a lift off from the null line as a visually inflated
QQ plot (Figure 3B). Since this could be due to multicollinearity,
we calculated the correlation coefficient between all FBC traits
(see Figure 4) in order to identify highly collinear variables.
Hemoglobin (Hgb) was found to be highly correlated with PCV
(r = 0.94) and MCH highly correlated with MCV (r = 0.92) (full
list in Supplementary Tables 1a,b). Repeating the analysis while
excluding PCV, MCH, Hgb, and LYM showed an expected QQ
plot (Figure 4A) and a conventional Manhattan plot with strong
genetics signal at expected chromosomes 11 and 16 (Figure 4B).
In this analysis, we examined multiple correlated traits while
taking into consideration issues with relatedness and population
stratification. We noted that the issues with multicollinearity that
manifest as inflated QQ plots, and unconventional Manhattan
plots are particularly due to rare variation. The inflation is mostly
for variants with <1% maf, but not all variants causing the
inflation are in this category. It seems that rare variants are much
more susceptible to unstable estimates with multi-collinearity.
This analysis provides a framework for the combination of
multiple phenotypes in multivariate GWAS analysis having
shown evidence of multi-collinearity whenever the correlation
between traits exceeds the correlation coefficient of r2 >=0.75.
Principal Component GWAS Method (PC-GWAS)
Usually, the PCA is an analytic approach used in GWAS
for examining population structure, especially within ethno-
linguistic groups. Previous studies (Biffi et al., 2010) have used
PCs as covariates in their analyses to correct for possible
biases induced by sample collection or non-genetic geographical
effects on phenotype. However, Ried et al. (2016) effectively
applied PCA approach to four correlated anthropometric traits
to encapsulate body shape and recommended the approach for
other correlated traits such as FBC traits. We explored this
approach to complement the standard multivariate GWAS we
described in the Section “Multivariate GWAS Method (MV-
GWAS).” We applied PCA to the same 15 correlated FBC
traits in the same transformed phenotypic dataset to generate a
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FIGURE 4 | (A) QQ plot of genome-wide associations for all FBC excluding highly correlated traits: PCV, MCH, Hgb, and LYM. (B) Manhattan plots of genome-wide
associations for all FBC after highly correlated traits: PCV, MCH, Hgb, and LYM were excluded from the analysis.
dimensional set of uncorrelated outcome PCs (Supplementary
Table 2). We then tested for marker associations with each PC
in the univariate linear mixed model in GEMMA. We show
that the FBC composite phenotype as assessed by each PC
articulates information that is not fully encapsulated by the
individual FBC phenotype as this approach identifies genome-
wide significant variants that were not identified using both the
standard univariate and multivariate GWAS.
Significance Thresholds for Multiple Testing
There are many methods such as Bonferroni or Sodak
for multiple comparisons tests. These methods exploit the
correlation structure between genetic variants to estimate the
effective number of independent tests, and then use standard
techniques for independent tests to calculate an appropriate
significance threshold. In standard univariate GWAS (such as
our UV-GWAS), the standard significance threshold of 5× 10−8
is mostly used. For our Mv-GWAS, GEMMA appropriately
adjusted for testing multiple phenotypes, so there was no need for
an additional correction, however, for PC-GWAS, the Bonferroni
correction for testing 15 orthogonal phenotypes obtained from
the principal components analysis of the 15 FBC phenotypes
(PC-GWAS) would be 5 × 10−8/15 (3.33 × 10−9). In order
to address the potential introduction of type II errors via the
application of this rigorous correction, we present all our results
using the standard genome-wide significant threshold of P-value
≤5 × 10−8 was met, but we highlight result with Bonferroni
corrected significant threshold.
RESULTS
For each strategy (UV-GWAS, MV-WAS, PC-GWAS), we
applied the typically significance threshold of p < 5.0E-08 to
define association. We defined a locus to be novel if it had
not been associated with any FBC trait in any previous GWAS
and its P-value is less than or equal to 5 × 10−8. In order to
define whether a locus was known or novel, we searched the
NHGRI database for loci reaching statistical significance at a level
5e-08 associated with FBC trait. This was supplemented by a
literature review.
Results for UV-GWAS
With UV-GWAS method, we analyzed each 15 trait individually
and identified 4 novel association signals. This method also
confirmed 4 known loci associated with blood traits (Table 2).
HBB
We identified important functional variants such as the sickle cell
variant (rs334) in the HBB gene associated with RDW. The HBB
locus is found to be associated with RBC distribution width in
our main standard univariate analysis. As previously observed
in regions affected with malaria, this variant has reached high
frequencies as a result of balancing selection because it can
provide resistance against the parasite, and reduces the severity
of malaria among carriers. This signal was also identified by
MV-GWAS and PC-GWAS.
ITFG3
We found 230 genome-wide statistical significant variants in
the known locus ITFG3 associated with RBC, MCV, MCH,
and MCHC. Though the function of ITFG3 is not known, it
is known to be expressed in an erythroleukemia cell line, and
other common SNPs of this gene have been implicated with red
blood cell indices in European and Asian GWASs (Chen et al.,
2013; Hodonsky et al., 2017). This signal was also identified by
MV-GWAS and PC-GWAS.
R3HDM1
UV-GWAS identified 277 genome-wide statistical significant
variants in association signal R3HDM1 gene on chromosome
2 with neutrophil count; this variant was common in African
populations (MAF = 10%), and monomorphic in Europeans. This
signal is reported in our study.
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TPM4
UV-GWAS found 4 genome-wide statistical significant variants
in the known locus TPM4. TPM4 plays a crucial role,
in association with the troponin complex, in the calcium
reliant on regulation of vertebrate striated muscle tightening
(Crabos et al., 1991).
CTB-30L5.1 and AC008834.1
Both CTB-30L5.1 and AC008834.1 are Uncharacterized, and
do not code for protein. CTB-30L5.1 is an RNA Gene which
is affiliated with the ncRNA class while AC008834.1 is a
processed pseudogene.
Results for MV-GWAS
Three association loci were identified using the MV-GWAS
approach, of which two (HBB and ITFG3) had been previously
reported to be associated with at least one of the FBC traits
(Table 3). These known associations were also identified using
the standard univariate and PC-GWAS approaches.
ATF3
We identified a common variant rs3123543 association with
blood in ATF3 (Figure 5). ATF3 interacts with TP53, JunD
proto-oncogene, JUN oncogene, CEBPB, and STAT1, among
others. Notably, CEBPB is a vital transcriptional activator in
the genes regulation engaged in hemopoiesis and immune and
inflammatory responses (Janz et al., 2006).
Results for PC-GWAS
Five novel association signals were identified using PC-GWAS
method (Table 4 and Supplementary Figure 2). It also found two
TABLE 3 | Description of genome-wide significant loci using MV-GWAS.
Peak SNP AF Association
count
Chr BP
(GRCh37)
Gene Pooled
analysis
P-value
rs3123543 0.354 1 1 212790686 ATF3 1.29E-08
rs334 0.923 56 11 5248232 HBB∗ 5.34E-20
rs13331259 0.897 158 16 299923 ITFG3∗ 7.84E-30
∗Known association; AF, allele frequency.
TABLE 4 | Genome-wide significant loci using PC-GWAS approach.
Peak SNP AF Association
count
Chr BP
(GRCh37)
Gene Pooled
analysis
P-value
rs7296503 0.723 2 12 41700764 PDZRN4+ 2.10E-09
rs112505971 0.948 21 10 27357470 ANKRD26 1.81E-08
rs4837892 0.652 1 9 124588304 TTLL11 2.99E-08
rs9917425 0.819 4 20 16736045 OTOR+ 6.77E-10
rs3840870 0.556 1 17 48262183 COL1A1 1.19E-08
rs334 0.923 22 11 5244665 HBB∗+ 1.15E-12
rs76792961 0.897 209 16 293593 ITFG3∗+ 6.70E-26
rs2853961 0.603 1 6 31231989 HLA-C∗+ 4.25E-08
∗Known association; AF, allele frequency. +Locus remain significant after applying
Bonferroni corrected threshold of 3.33 × 10−9.
known associations (HBB and ITFG3) that had been previously
reported to be associated with at least one of the fifteen FBC traits.
These known associations were also identified with UV-GWAS
and MV-GWAS approaches and were described in the Sections
“ITFG3 and R3HDM1.”
PDZRN4
Two genome-wide statistical significant SNPs were identified
in PDZRN4 (Figure 6). The locus enlarged epidermal growth
factor receptor (EGFR) surface abundance and thus reduced
homologous recombination repair frequency, the Negative
genetic interaction between MUS81−/− and MUS81+/+,
Decreased viability, Increased vaccinia virus (VACV) infection
(Sivan et al., 2013) The gene is expressed in the lymph node,
colon, bladder, whole blood, among other organs.
ANKRD26
We identified 21 genome-wide association variants at this
locus (rs112505971, P-value 1.81e-08) (Figure 7). The variant
(rs112505971) is common in Ugandan populations, with
allele frequency of 0.948. It is noted that the variant is
monomorphic in East and South Asian populations but very
rare in Ad Mixed American and European populations with
maf of 0% in 1000 genomes project. ANKRD26 (Ankyrin
Repeat Domain 26) is a Protein-Coding gene. The peak
variant is common in Uganda (5%) but absent in EUR and
EAS populations. In Clinvar, ANKRD26 is known to be
associated Thrombocytopenia 2. This is an autosomal dominant
non-syndromic condition which is delineated by reduced
numbers of standard platelets, resulting in a moderate bleeding
inclination (Pippucci et al., 2011).
TTLL11
rs4837892 in TTLL11 (tubulin tyrosine ligase-like family) is
associated with FBC (Figure 8). TTLL11 is expressed in 119
organs including whole blood, white blood cells, lymph node, and
cervical spinal cord.
OTOR
We identified four novel genome-wide statistical variants at
chromosome 20 in the gene OTOR. This gene is known to be
associated with posttraumatic stress disorder in GWAS catalog
(Xie et al., 2013).
COL1A1
One variant was identified in the gene COL1A1 to be associated
with blood cell. This gene encodes the pro-alpha1 chains of type
I collagen whose triple helix comprises two alpha1 chains and
one alpha2 chain. The COL1A1 gene provides instructions for
making part of a large molecule called type I collagen.
Comparison of Genome-Wide Statistical
Significant Association Loci Found by
UV-GWAS, MV-GWAS, and PC-GWAS
Collectively, the three methods identified fifteen loci including
ten novel loci associated with FBC traits. Two of the novel loci
are intergenic variants and not shown in Figure 9.
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FIGURE 5 | Regional visualization of the GWAS of –log10 of the P-value of genomic location ATF3 (rs3123543 in purple), with each dot representing a SNP on the
corresponding genes at the bottom.
FIGURE 6 | Regional visualization of the GWAS of –log10 of the P-value of genomic location PDZRN4 (rs7296503 in purple), with each dot representing a SNP on
the corresponding genes at the bottom.
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FIGURE 7 | Regional visualization of the GWAS of –log10 of the P-value of genomic location ANKRD26 (rs112505971 in purple), with each dot representing a SNP
on the corresponding genes at the bottom.
FIGURE 8 | Regional visualization of the GWAS of –log10 of the P-value of genomic location TTLL11 (rs4837892 in purple), with each dot representing a SNP on the
corresponding genes at the bottom.
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FIGURE 9 | Venn diagram comparing the loci found by PC-GWAS and
MV-GWAS in comparison with UV-GWAS. Two known loci HBB and ITFG3
were identified all the three methods. Two novel intergenic variants identified
by UV-GWAS not shown.
DISCUSSION
To assess the spectrum of genetic variants associated with
FBC traits in Uganda, we performed standard univariate and
two multivariate GWAS methods to examine association of
15 FBC traits in 6407 individuals in a pooled data from
UGWAS with UG2G sequence data. Across the three methods,
we identified eight novel loci. They include ATF3 (rs3123543)
using MV-GWAS strategy, PDZRN4 (rs7296503), ANKRD26
(rs112505971) and TTLL11 (rs4837892), OTOR (rs9917425),
COL1A1 (rs3840870) using PC-GWAS strategy and AC008834.1
(rs7725036), CTB-30L5.1 (rs12534473), two intergenic variants
(rs142586351, rs2769976) using UV-GWAS. As a proof of
concept, both methods also identified known associated loci
HBB and ITFG3. Additionally, UV-GWAS solely identified
an additional variant at known loci TPM4 and R3HDM1
while PC-GWAS exclusively identified known association locus
HLA-C. The MV-GWAS has been reported to be especially
powerful when the genetic correlation between traits differs
from the environmental. I think this effect is not present in
the PC-GWAS, because it makes PCs based on phenotypic
correlations. Therefore the two methods can be sensitive for
different correlation patterns between the traits. The methods
complement one another and show also show that multivariate
genotype-phenotype methods increase power and identify novel
genotype-phenotype associations not found with univariate
GWAS in the same dataset.
One limitation of the MV-GWAS approach is its sensitivity
to highly correlated traits. Sensitivity analyses showed that
issues with multicollinearity may occur, that manifest as inflated
QQ plots, and unconventional Manhattan plots particularly
due to rare variation using the MV-GWAS strategy. The
inflation is mostly for variants with <1% maf, but not all
variants causing the inflation are in this category. It seems
that rare variants are much more susceptible to unstable
estimates with multicollinearity. Evidence of multi-collinearity
was seen whenever the correlation between traits exceeded
the ±0.75 threshold in MV-GWAS strategy. However, this
approach exclusively identified a novel locus ATF3 with
generally lower P-values compare to the standard univariate and
PC-GWAS methods.
Though the PC-GWAS approach captured well the variation
across FBC traits simultaneously in this study and identified
more novel loci compare with the other two methods, it
cannot be a replacement for both the standard univariate
GWAS and MV-GWAS because there are still a number of
known loci that were not identified by PC-GWAS in our
study but were identified in the standard univariate GWAS
(e.g., R3HDM1, TPM4).
To demonstrate the strength of these multivariate GWAS
methods when used to complement each other, we collectively
identified six novel loci (ANKRD26, PDZRN4, COL1A1,
OTOR, TTLL11, ATF3) subject to replication and both
methods also identified three known association loci (HBB,
ITFG3, HLA-C). The multivariate methods evidence that
multivariate genotype-phenotype method increase power and
thus identify novel genotype-phenotype associations not found
with univariate GWAS in the same dataset. Though the MV-
GWAS improves P-value much better, the PC-GWAS strategy
found more novel loci.
These multivariate methods could maximize novel loci
discovery for other correlated phenotypes, such as lipid traits,
liver function, cancers, anthropometry, immune disease, and
others and might help to speed up drug discovery across a range
of Cardiometabolic traits as previous studies have shown that
FBC may serve as markers of proinflammatory state of metabolic
syndrome and promoter of atherosclerotic risk (Jesri et al., 2005;
Kotani et al., 2007; Kelishadi et al., 2010).
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